HB 2470

  • Virginia House Bill
  • 2017 Regular Session
  • Introduced in House Jan 20, 2017
  • House
  • Senate
  • Signed by Governor Mar 16, 2017

Drug Control Act; Schedule II and Schedule V.

Abstract

Adds thiafentanil to Schedule II of the Drug Control Act and brivaracetam to Schedule V of the Drug Control Act.

Bill Sponsors (1)

Votes


Actions


Mar 16, 2017

Office of the Governor

Approved by Governor-Chapter 612 (effective 7/1/17)

Feb 28, 2017

Virginia General Assembly

Enrolled Bill communicated to Governor on 2/28/17

Office of the Governor

Governor's Action Deadline Midnight, March 27, 2017

Feb 24, 2017

Virginia General Assembly

Enrolled

Virginia General Assembly

Signed by Speaker

Virginia General Assembly

Signed by President

Feb 21, 2017

Virginia General Assembly

Read third time

Feb 16, 2017

Virginia General Assembly

Rereferred to Finance

Feb 08, 2017

Virginia General Assembly

Constitutional reading dispensed

Virginia General Assembly

Referred to Committee on Education and Health

Feb 07, 2017

Virginia General Assembly

Read third time and passed House BLOCK VOTE (97-Y 0-N)

Feb 06, 2017

Virginia General Assembly

Read second time and engrossed

Feb 04, 2017

Virginia General Assembly

Read first time

Jan 27, 2017

Virginia General Assembly

Assigned App. sub: Public Safety

Jan 26, 2017

Virginia General Assembly

Referred to Committee on Appropriations

Jan 20, 2017

Virginia General Assembly

Referred to Committee on Health, Welfare and Institutions

Virginia General Assembly

Presented and ordered printed 17104071D

Bill Text

Bill Text Versions Format
House: Presented and ordered printed 17104071D HTML
House: Bill text as passed House and Senate (HB2470ER) HTML
Governor: Acts of Assembly Chapter text (CHAP0612) HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.